Identical MicroRNAs Regulate Liver Protection during Anaesthetic and Ischemic Preconditioning in Rats: An animal

Tomonori Morita1, Masashi Ishikawa1, Atsuhiro Sakamoto1

  • 1Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan.

Plos One
|May 15, 2015
PubMed

Insights

Both anesthetic preconditioning (APC) and ischemic preconditioning (IPC) protect the liver from injury by regulating common microRNAs (miRNAs) involved in the Akt-GSK-3β-cyclin D1 pathway.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Anesthesiology

Background:

  • Liver ischemia-reperfusion (I/R) injury is a significant clinical challenge.
  • Anesthetic preconditioning (APC) and ischemic preconditioning (IPC) are known to mitigate hepatic I/R injury.
  • MicroRNAs (miRNAs) play crucial roles in regulating gene expression and cellular processes.

Purpose of the Study:

  • To investigate whether APC and IPC employ the same miRNA mechanisms in protecting against liver I/R injury.
  • To identify specific miRNAs and pathways affected by both preconditioning strategies.

Main Methods:

  • A rat model of hepatic I/R injury was used, with groups for control, APC (sevoflurane), and IPC.
  • Comprehensive miRNA screening was performed on liver samples post-reperfusion.
  • Ingenuity Pathway Analysis (IPA) was utilized to identify affected gene networks and pathways.
  • Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured.

Main Results:

  • Both APC and IPC significantly reduced AST and ALT levels compared to the control group.
  • Most miRNA alterations observed in the APC group were also present in the IPC group.
  • Five specific miRNAs involved in the Akt-glycogen synthase kinase-3β (GSK-3β)-cyclin D1 pathway were significantly modulated by both APC and IPC.

Conclusions:

  • APC and IPC utilize overlapping miRNA profiles to confer protection against hepatic I/R injury.
  • The Akt-GSK-3β-cyclin D1 pathway is a key molecular mechanism targeted by both preconditioning methods.
  • These findings suggest potential therapeutic strategies for managing liver I/R injury.

Related Concept Videos